Long-term Respiratory Complications in Infants With Perinatal COVID-19

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

June 7, 2022

Primary Completion Date

May 7, 2025

Study Completion Date

May 30, 2025

Conditions
COVID-19Infant, Newborn, DiseasesRespiratory Function Tests
Interventions
DIAGNOSTIC_TEST

Pulmonary function testing device

Patients will undergo pulmonary function tests with the Exhalyzer D (Ecomedics, Switzerland) device. This device consists of 1) an ultrasonic flow measuring system for measuring flow, volume and molecular mass, 2) a nitrogen washout system to measure functional residual capacity (FRC) and other indices, 3) a carbon dioxide infrared measurement device for monitoring the level of carbon dioxide in exhaled breath.

Trial Locations (1)

00168

Fondazione Policlinico Gemelli IRCCS, Roma

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER